FDA Import Refusal SCS-2985460-6/10003/1 — DAEWOONG PHARMACEUTICAL CO LTD
The FDA refused shipment SCS-2985460-6/10003/1 from DAEWOONG PHARMACEUTICAL CO LTD (South Korea) on Oct 16, 2025. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 16, 2025
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58PCY05 ONABOTULINUMTOXINA
- Charges
- 75